Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker.
AbbVie Inc. agreed to pay $130m up front on 1 March to acquire privately held Syndesi Therapeutics SA...






